Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on October 30, 2015, to consider and approve, Unaudited Financial Results for the second quarter and half year September 30, 2015 (Q2).
The above information is a part of company’s filings submitted to BSE.